ARCHIVE

• REGULATORY NEWS IN BRIEF
  May 12, 2003

• Takeda Aims to Become World-class Company Under New CEO, COO
  May 12, 2003

• Changeover to Generics Will Not Progress as Planned: Dr Nishioka
  May 12, 2003

• BUSINESS NEWS IN BRIEF
  May 12, 2003

• WEBSITE NEWS
  May 12, 2003

• Medical Fee Revision Should Promote Optimal Patient Care: Dr Itouji of JMA
  May 12, 2003

• Only 1 Drug Received Premium for Innovation Since FY2002 Reform: HIB
  April 28, 2003

• BULLETIN
  April 28, 2003

• Committee Recommends Approval of Folinate/Tegafur/Uracil Therapy for Colorectal Cancer
  April 28, 2003

• MEDICAL DIVICE NEWS IN BRIEF
  April 28, 2003

• 18 New Products Including Arava, Capecitabine Receive Formal Approval
  April 28, 2003

• Japan's Makers Must Extricate Themselves from Out-licensing Patterns: FPMAJ President
  April 28, 2003

• Safety Measures for Cattle-derived Materials Strengthend
  April 28, 2003

• Mixing of Insurance-covered, Non-covered Care Difficult in Japan: Prof Ikegami
  April 28, 2003

• Pharmaceutical Industry Has Entered a Paradigm Shift: OPSR President
  April 28, 2003

• Nat'l Univ Hospitals Have to Report Serious Medical Accidents
  April 28, 2003

• REGULATORY NEWS IN BRIEF
  April 28, 2003

• ON THE MOVE
  April 28, 2003

• DPC System Introduced at 15 Hospitals on April 1: PJ Survey
  April 28, 2003

• Drug Makers' Cooperation Sought in Providing Drugs for Physician-led Clinical Trials: Ihoken Meeting
  April 28, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 601
• 602
• 603
• 604
• 605
• 606
• 607
• 608
• 609
• …
• Next ›
• 最終 »